{"id":250,"date":"2019-10-08T18:03:41","date_gmt":"2019-10-08T16:03:41","guid":{"rendered":"https:\/\/xinnate.com\/?page_id=250"},"modified":"2024-05-05T19:01:04","modified_gmt":"2024-05-05T17:01:04","slug":"strategy","status":"publish","type":"page","link":"https:\/\/xinnate.com\/strategy\/","title":{"rendered":"Strategy"},"content":{"rendered":"

[vc_row row_height_percent=”100″ override_padding=”yes” h_padding=”2″ top_padding=”5″ bottom_padding=”5″ back_color=”color-wayh” back_image=”144″ overlay_color=”color-jevc” overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″][vc_row_inner][vc_column_inner column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″][vc_custom_heading text_color=”accent” heading_semantic=”h6″ text_size=”h6″ text_transform=”uppercase” sub_lead=”yes”]About[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”h1″]Strategy[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_visibility=”yes” medium_width=”0″ mobile_visibility=”yes” mobile_width=”0″ width=”1\/2″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″ uncode_shortcode_id=”524430″][vc_column_text uncode_shortcode_id=”936964″]Xinnate currently develops the first application with TCP-25 as the active pharmaceutical ingredient. The TCP-25 gel is currently in the clinical phase 1 development stage. The next step involves leveraging the TCP-25 platform to expand and develop a diverse portfolio of applications.[\/vc_column_text][\/vc_column_inner][vc_column_inner column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″][vc_column_text uncode_shortcode_id=”185668″]The overarching strategy is to advance each drug concept to a stage where a commercial deal with a larger pharmaceutical company possessing a global presence can be achieved. These transactions may involve out-licensing, partnering, licensing, strategic partnerships, joint ventures, or the sale of assets[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″][vc_column_text text_lead=”yes”]Read more about our:[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=”0″ overlay_alpha=”50″ gutter_size=”3″ shift_y=”0″ z_index=”0″ css=”.vc_custom_1571386071177{padding-right: 150px !important;padding-left: 150px !important;}”][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/6″][\/vc_column_inner][vc_column_inner width=”1\/6″][\/vc_column_inner][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/6″][vc_button button_color=”accent” size=”btn-sm” radius=”btn-round” outline=”yes” border_width=”0″ link=”url:https%3A%2F%2Fxinnate.com%2Fidea%2F|title:Idea||”]Idea[\/vc_button][\/vc_column_inner][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/6″][vc_button button_color=”accent” size=”btn-sm” radius=”btn-round” outline=”yes” border_width=”0″ link=”url:https%3A%2F%2Fxinnate.com%2Fconcept%2F|title:Idea||”]Concept[\/vc_button][\/vc_column_inner][vc_column_inner width=”1\/6″][\/vc_column_inner][vc_column_inner width=”1\/6″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row row_height_percent=”100″ override_padding=”yes” h_padding=”2″ top_padding=”5″ bottom_padding=”5″ back_color=”color-wayh” back_image=”144″ overlay_color=”color-jevc” overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/pages\/250"}],"collection":[{"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/comments?post=250"}],"version-history":[{"count":20,"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/pages\/250\/revisions"}],"predecessor-version":[{"id":2041,"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/pages\/250\/revisions\/2041"}],"wp:attachment":[{"href":"https:\/\/xinnate.com\/wp-json\/wp\/v2\/media?parent=250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}